Pages that link to "Q37684406"
Jump to navigation
Jump to search
The following pages link to Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome (Q37684406):
Displaying 50 items.
- Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part II - contemporary contextual research (Q21198786) (← links)
- Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health (Q26738283) (← links)
- Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye? (Q26765219) (← links)
- Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome (Q26765272) (← links)
- Diagnosis and management of functional symptoms in inflammatory bowel disease in remission (Q26768264) (← links)
- Gut microbiota role in irritable bowel syndrome: New therapeutic strategies (Q26768550) (← links)
- Colonization resistance: battle of the bugs or Ménage à Trois with the host? (Q26824307) (← links)
- Application of metagenomics in the human gut microbiome (Q26851464) (← links)
- Irritable bowel syndrome: a concise review of current treatment concepts (Q26996547) (← links)
- Collateral damage: microbiota-derived metabolites and immune function in the antibiotic era (Q27000267) (← links)
- Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis (Q27001712) (← links)
- Unraveling the ties between irritable bowel syndrome and intestinal microbiota (Q27004645) (← links)
- Effects of a high fat diet on intestinal microbiota and gastrointestinal diseases (Q28069204) (← links)
- Can probiotics benefit children with autism spectrum disorders? (Q28076833) (← links)
- Gut microbiota as potential orchestrators of irritable bowel syndrome (Q28085584) (← links)
- Can probiotics modulate human disease by impacting intestinal barrier function? (Q28817192) (← links)
- Disruption of the human gut microbiota following Norovirus infection (Q30424368) (← links)
- Mechanisms and efficacy of dietary FODMAP restriction in IBS. (Q30738587) (← links)
- Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome (Q33465766) (← links)
- Frequency of abnormal fecal biomarkers in irritable bowel syndrome (Q33648553) (← links)
- Novel Testing Enhances Irritable Bowel Syndrome Medical Management: The IMMINENT Study (Q33648576) (← links)
- Therapy of the postinfectious irritable bowel syndrome: an update (Q33693294) (← links)
- Methodological issues in the study of intestinal microbiota in irritable bowel syndrome (Q33958776) (← links)
- Microbial population analysis of the salivary glands of ticks; a possible strategy for the surveillance of bacterial pathogens (Q33999655) (← links)
- The microbiota-gut-brain axis in functional gastrointestinal disorders (Q34129427) (← links)
- Alterations of microbiota in urine from women with interstitial cystitis (Q34413923) (← links)
- Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects (Q34445992) (← links)
- Characterization of the fecal microbiota using high-throughput sequencing reveals a stable microbial community during storage (Q34447653) (← links)
- The role of Blastocystis sp. and Dientamoeba fragilis in irritable bowel syndrome: a systematic review and meta-analysis (Q34558427) (← links)
- Gut microbiota patterns associated with colonization of different Clostridium difficile ribotypes (Q34612756) (← links)
- Fecal microbial diversity in pre-weaned dairy calves as described by pyrosequencing of metagenomic 16S rDNA. Associations of Faecalibacterium species with health and growth (Q34707084) (← links)
- Intestinal microbiota in healthy U.S. young children and adults--a high throughput microarray analysis. (Q34745707) (← links)
- Altered enteric microbiota ecology in interleukin 10-deficient mice during development and progression of intestinal inflammation (Q34792072) (← links)
- Fecal protease activity is associated with compositional alterations in the intestinal microbiota (Q35023520) (← links)
- Why related bacterial species bloom simultaneously in the gut: principles underlying the 'Like will to like' concept (Q35056059) (← links)
- Altered profile of human gut microbiome is associated with cirrhosis and its complications (Q35077209) (← links)
- Comparison of the bacterial composition and structure in symptomatic and asymptomatic endodontic infections associated with root-filled teeth using pyrosequencing (Q35081102) (← links)
- Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. (Q35105259) (← links)
- Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? (Q35130335) (← links)
- Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets (Q35130485) (← links)
- Germ-free mice as a model to study effect of gut microbiota on host physiology (Q35173933) (← links)
- Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress. (Q35529596) (← links)
- The structures of the colonic mucosa-associated and luminal microbial communities are distinct and differentially affected by a prolonged murine stressor (Q35533302) (← links)
- Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial. (Q35586987) (← links)
- Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome. (Q35599906) (← links)
- High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals (Q35615264) (← links)
- Recent developments in the pathophysiology of irritable bowel syndrome (Q35689193) (← links)
- Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation. (Q35804351) (← links)
- Characterising the bacterial microbiota across the gastrointestinal tracts of dairy cattle: membership and potential function (Q35829996) (← links)
- Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea (Q35855740) (← links)